Share on StockTwits

Udg Healthcare PLC (LON:UDG)‘s stock had its “buy” rating reaffirmed by N+1 Singer in a research note issued on Monday. They currently have a GBX 410 ($6.85) target price on the stock. N+1 Singer’s price target indicates a potential upside of 19.54% from the company’s current price.

Shares of Udg Healthcare PLC (LON:UDG) traded up 0.85% on Monday, hitting GBX 345.60. 39,356 shares of the company’s stock traded hands. Udg Healthcare PLC has a 1-year low of GBX 293.30 and a 1-year high of GBX 380.10. The stock’s 50-day moving average is GBX 347.8 and its 200-day moving average is GBX 351.3. The company’s market cap is £834.3 million.

Other equities research analysts have also recently issued reports about the stock. Analysts at Davy Research reiterated an “outperform” rating on shares of Udg Healthcare PLC in a research note on Friday, August 1st. Separately, analysts at Goodbody Stockbrokers Ltd reiterated a “buy” rating on shares of Udg Healthcare PLC in a research note on Tuesday, July 8th. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. Udg Healthcare PLC has an average rating of “Buy” and a consensus target price of GBX 381.25 ($6.37).

UDG Healthcare plc is an international provider of services to healthcare manufacturers and pharmaceutical retailers.

Receive News & Ratings for Udg Healthcare PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.